MEDICAL DEVICE INNOVATION - Medical Device Daily

More documents

Recommendations

Info

110 MEDICAL DEVICE INNOVATION 2010 of treatment is critically important, the company says, if the nerve bundles for potency, and the continence of the urethra and rectum are to be spared. Current management strategies for localized prostate cancer include watchful waiting, radiation therapy, active surveillance (periodic biochemical monitoring with conversion to curative treatment if disease progresses), radical prostatectomy, and brachytherapy (or radioactive seed implantation therapy). Other companies also are working to provide a treatment for prostate cancer without the side effects of conventional radiation therapy. Recognizing that movement of the prostate during treatment is one of the major limiting factors of prostate cancer treatment, Accuray (Sunnyvale, California) introduced a device last year, the InTempo adaptive imaging system, to help radiologists overcome the challenge. The imaging device is designed to enhance the CyberKnife robotic radiosurgery system’s ability to track and correct for motion of the prostate during treatment. The system is like an artificial intelligence that calculates where the prostate is. The more the device sees the organ moving, the faster the pictures are taken, automatically correcting the robot. (This story originally appeared in the Feb. 10, 2009, edition of Medical Device Daily) To subscribe, please call MEDICAL DEVICE DAILY Customer Service at (800) 888-3912; outside the U.S. and Canada, call (404) 262-5547. Copyright © 2010 AHC Media LLC. Reproduction is strictly prohibited.
MEDICAL DEVICE INNOVATION 2010 Prostate mechanical imaging may improve cancer detection By LYNN YOFFEE Medical Device Daily Staff Writer The diagnosis and treatment of prostate cancer is rife with controversy. Because it’s such a slow-growing cancer and therapy carries significant risks, a case can be made to skip treatments altogether. But for men whose prostate cancers happen to be fast growing – or near the prostate wall – it’s imperative to get an early, accurate diagnosis. Akin to the function of mammography, the ProUroScan is a new medical imaging technology that creates a map or a digital record of the prostate to identify abnormalities detected by digital rectal exam (DRE). “When we survey the prostate with our probe, we create a map, a 3-D picture of what a prostate would look like,” Rick Carlson, CEO of ProUroCare Medical (Minneapolis), told Medical Device Daily. “Once we create the map for any patient with any condition of any type, it creates a baseline, which says we have a patient with a suspicious condition and now we know where it exists.” That map, created by this new method called prostate mechanical imaging (PMI), can be saved as a permanent electronic record and compared to other maps created in successive evaluations. The American Cancer Society (Atlanta) estimates that there are more than two million men in the U.S. diagnosed with prostate cancer. One out of 35 men will die from this type of cancer, but it’s difficult to identify those with aggressive disease. The two primary screening tests for prostate cancer, the DRE and the prostate specific antigen (PSA) blood test, are not 100% accurate. An abnormal result isn’t a confirmation of cancer and a normal result doesn’t mean cancer isn’t present. Biopsies are another option, but unless the needle hits cancerous tissue, it can be missed. Given these concerns and complications, ProUroCare has taken a different approach to the diagnostic process. “Any soft tissue organ, by definition, does not generally have abnormal tissue formations unless there is something going on,” Carlson said. “The map created by ProUroScan is akin to a weather map. We’re measuring the displacement of tissue. The more tissue you displace the lighter the color. “Any dark formations are an indication that elasticity is different. Over time, we’ll be able to say that tissue is not only different, but in fact is most likely a cancer formation. As we see changes in the sizes in the elasticity being different it tells us if it’s expanding or moving closer to the wall of the prostate. All are indications for physician that you may have a more progressive disease or a more benign disease.” Carlson explained that PMI is not ultrasound or thermal mapping, but a mechanical mapping done with the aid of a probe equipped with pressure sensor arrays. 111 “We would see this test being done repeatedly over time so that a physician would be able to compare changes that occur,” he said. To date, nine peer-reviewed articles have been published, the latest of which was in Urology last year. That study, led by ProUroScan co-inventor Armen Sarvazyan, PhD, founder and CSO of Artann Laboratories (Trenton, New Jersey), presented data from 168 patients. In 84% of cases, PMI provided “data sufficient for quantitative assessment and image reconstruction of the prostate,” the study authors wrote. “Four potential causes of the 16% failure became apparent: anatomical limitations such as position of the prostate relative to sphincter and/or bladder (5%), insufficient pressure applied (5%), excessive noise from sensors (4%), and inability of the examiner to locate the prostate upon insertion of the probe (2%).” PMI successfully imaged 10 of 13 malignant nodules and was consistent with all eight reported biopsy-negative cases. For the same group, the DRE identified six of 13 cancer-positive cases and produced one false-positive result in the eight non-cancerous cases. Overall, the study authors agreed that PMI “may significantly add to the technology diagnostic potential.” ProUroCare has since launched a new 40-patient study as required by the FDA for 510(k) approval that’s expected to be completed in August. If approved and launched, Carlson said the system, basically a small computer with a probe attached, would cost under $10,000 and would be used in a physician’s office if either a DRE or PSA test were suspicious. “Our goals is to make this a non-capital system purchase,” he said, comparing it to the average $150,000 cost of an ultrasound machine. “We would see physicians having it in their offices and keeping their own images to compare over time. Initially, the test (estimated to be $200) would have to be paid for by patients out of pocket but the company intends to pursue CPT coding. Last year, ProUroCare entered into two agreements with Artann to complete development, conduct clinical trials and file for FDA clearance for ProUroScan (MDD, August 1, 2008). If ProUroScan is approved for marketing, Carlson said the company will seek out a relationship with a larger medical device firm for marketing and distribution rather than building its own sales force. (This story originally appeared in the July 13, 2009, edition of Medical Device Daily). To subscribe, please call MEDICAL DEVICE DAILY Customer Service at (800) 888-3912; outside the U.S. and Canada, call (404) 262-5547. Copyright © 2010 AHC Media LLC. Reproduction is strictly prohibited.
Page 1 and 2:
MEDICAL DEVICE DAILY MEDICAL DEVIC
Page 3 and 4:
MEDICAL DEVICE INNOVATION 2010 1 AB
Page 5 and 6:
MEDICAL DEVICE INNOVATION 2010 3 Ta
Page 7 and 8:
MEDICAL DEVICE INNOVATION 2010 5 In
Page 9 and 10:
MEDICAL DEVICE INNOVATION 2010 A ti
Page 11 and 12:
MEDICAL DEVICE INNOVATION 2010 9 do
Page 13 and 14:
MEDICAL DEVICE INNOVATION 2010 Hear
Page 15 and 16:
MEDICAL DEVICE INNOVATION 2010 ARS
Page 17 and 18:
MEDICAL DEVICE INNOVATION 2010 15 b
Page 19 and 20:
MEDICAL DEVICE INNOVATION 2010 17 T
Page 21 and 22:
MEDICAL DEVICE INNOVATION 2010 Avan
Page 23 and 24:
MEDICAL DEVICE INNOVATION 2010 Body
Page 25 and 26:
MEDICAL DEVICE INNOVATION 2010 Came
Page 27 and 28:
MEDICAL DEVICE INNOVATION 2010 25 t
Page 29 and 30:
Page 31 and 32:
MEDICAL DEVICE INNOVATION 2010 29 2
Page 33 and 34:
MEDICAL DEVICE INNOVATION 2010 Coru
Page 35 and 36:
MEDICAL DEVICE INNOVATION 2010 33 s
Page 37 and 38:
MEDICAL DEVICE INNOVATION 2010 Surg
Page 39 and 40:
MEDICAL DEVICE INNOVATION 2010 Chee
Page 41 and 42:
Page 43 and 44:
MEDICAL DEVICE INNOVATION 2010 Cohe
Page 45 and 46:
MEDICAL DEVICE INNOVATION 2010 FDA
Page 47 and 48:
MEDICAL DEVICE INNOVATION 2010 45 c
Page 49 and 50:
MEDICAL DEVICE INNOVATION 2010 Enfa
Page 51 and 52:
MEDICAL DEVICE INNOVATION 2010 Drex
Page 53 and 54:
MEDICAL DEVICE INNOVATION 2010 Ekos
Page 55 and 56:
MEDICAL DEVICE INNOVATION 2010 53 I
Page 57 and 58:
MEDICAL DEVICE INNOVATION 2010 55 w
Page 59 and 60:
MEDICAL DEVICE INNOVATION 2010 Exmo
Page 61 and 62: MEDICAL DEVICE INNOVATION 2010 Endo
Page 63 and 64: MEDICAL DEVICE INNOVATION 2010 Broa
Page 65 and 66: MEDICAL DEVICE INNOVATION 2010 Heal
Page 67 and 68: MEDICAL DEVICE INNOVATION 2010 Stud
Page 69 and 70: MEDICAL DEVICE INNOVATION 2010 ExAb
Page 71 and 72: MEDICAL DEVICE INNOVATION 2010 69 J
Page 73 and 74: MEDICAL DEVICE INNOVATION 2010 71 c
Page 75 and 76: MEDICAL DEVICE INNOVATION 2010 Hybr
Page 77 and 78: MEDICAL DEVICE INNOVATION 2010 Tru-
Page 79 and 80: MEDICAL DEVICE INNOVATION 2010 77 L
Page 81 and 82: MEDICAL DEVICE INNOVATION 2010 Lumi
Page 83 and 84: MEDICAL DEVICE INNOVATION 2010 81 t
Page 85 and 86: MEDICAL DEVICE INNOVATION 2010 MTI
Page 87 and 88: MEDICAL DEVICE INNOVATION 2010 Micr
Page 89 and 90: MEDICAL DEVICE INNOVATION 2010 Nano
Page 91 and 92: MEDICAL DEVICE INNOVATION 2010 89 s
Page 93 and 94: MEDICAL DEVICE INNOVATION 2010 91 A
Page 95 and 96: MEDICAL DEVICE INNOVATION 2010 93 m
Page 97 and 98: MEDICAL DEVICE INNOVATION 2010 NiTi
Page 99 and 100: MEDICAL DEVICE INNOVATION 2010 NMT
Page 101 and 102: MEDICAL DEVICE INNOVATION 2010 Tran
Page 103 and 104: MEDICAL DEVICE INNOVATION 2010 New
Page 105 and 106: MEDICAL DEVICE INNOVATION 2010 Paci
Page 107 and 108: MEDICAL DEVICE INNOVATION 2010 105
Page 111: MEDICAL DEVICE INNOVATION 2010 Non-
Page 117 and 118: MEDICAL DEVICE INNOVATION 2010 Sanu
Page 119 and 120: MEDICAL DEVICE INNOVATION 2010 Clos
Page 121 and 122: MEDICAL DEVICE INNOVATION 2010 Once
Page 123 and 124: MEDICAL DEVICE INNOVATION 2010 SFC
Page 125 and 126: MEDICAL DEVICE INNOVATION 2010 Mayo
Page 127 and 128: MEDICAL DEVICE INNOVATION 2010 C-Pu
Page 129 and 130: MEDICAL DEVICE INNOVATION 2010 supe
Page 131 and 132: MEDICAL DEVICE INNOVATION 2010 Syne
Page 135 and 136: MEDICAL DEVICE INNOVATION 2010 Ther
Page 137 and 138: MEDICAL DEVICE INNOVATION 2010 Gold
Page 139 and 140: MEDICAL DEVICE INNOVATION 2010 Nano
Page 143 and 144: MEDICAL DEVICE INNOVATION 2010 Pilo
Page 145 and 146: MEDICAL DEVICE INNOVATION 2010 US E
Page 151 and 152: MEDICAL DEVICE INNOVATION 2010 A ti
Page 153 and 154: MEDICAL DEVICE INNOVATION 2010 VisE
Page 157: MEDICAL DEVICE INNOVATION 2010 155
show all

MEDICAL DEVICE INNOVATION - Medical Device Daily

Create successful ePaper yourself

Delete template?

Save as template?